Drosoprom
Analyst
T.D. Cowen
Equibles does not estimate personal net worth.
About Drosoprom
Drosoprom is recorded as Analyst at T.D. Cowen. Drosoprom has spoken on 1 earnings call across 1 company, most recently for Jazz Pharmaceuticals plc on May 5, 2026. The companies whose calls Drosoprom spoke on are classified in the Healthcare sector.
Drosoprom on recent calls
“Do you have any updated thoughts on sort of the size of this patient population? I think historically it was thought that it was maybe 2,000 or 3,000, but it says like something already hitting, you know, 500 patients.”
Affiliation history
-
T.D. Cowen
Analyst
Transcript header (unverified)
Current